Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Invitation to offer for NHS National Generic Pharmaceuticals - Imatinib and Valganciclovir
Offer reference number: CM/PHG/18/5573
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 17 months
Potential periods of call-offs under the framework agreement:
All products and all regions: 11 May 2019 to 31 January 2020 (8.5 months)
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Please see list of awarded suppliers (Including SME status) at t | - | £2,763,678 | - |